Abstract
I. Introduction

26
Increasing evidence has shown that blood cell counts or ratio, such as the WBC count, 27 absolute neutrophil counts (ANC), absolute lymphocyte counts (ALC), and neutrophil-to-28 lymphocyte ratio (NLR), are independent prognostic factors in cancer (1-6). Moreover, NLR 29 could be addressed as a biomarker for the degree of natural and adaptive immune response 30 against tumor (7-11).
31
While these leukocyte parameters are systemic biomarkers of host immunity, tumor-32 infiltrating lymphocytes (TILs) are tissue-based biomarkers for adaptive immune response.
33
TILs, which are directly measured in malignant tissues, have been highlighted as a biomarker 34 for predicting treatment response to chemotherapy in patients with breast cancer (9, 12-17).
35
The level of TILs is directly influenced by the host immune system because it is a product of 36 tumor-host immune interactions. Thus, it is worthwhile to explore the relationship between
37
TILs and host immunity. Among the various modalities for assessing host immunity function, 38 peripheral blood cell count is the easiest and most convenient to perform. However, the 39 relationship between TILs and blood cell counts in patients with breast cancer is unclear. Here, 
Assessment of TIL scores and definition of LPBC
57
The TIL score was evaluated as previously described (18, 19 
68
In this study, lymphocyte-predominant breast cancer (LPBC) was defined as tumors 69 having high TIL levels (≥50%). The cut-off point of 50% was set according to previous studies 70 using treatment-naïve surgical specimen (5, 13). 
78
In our study, ER and PR positivity were defined as an Allred score ≥ 3. HER2 staining was In addition, the mean ANC of the LPBC group was significantly higher than that of 138 the non-LPBC (P=0.003; Fig 1A) . However, means of ALC and NLR did not differ between 139 two groups (Fig 1B, P=0.677; Fig 1C, P=0. 196, respectively). 
Association between TILs and blood cell markers
147
We compared the means of the blood cell markers among the subtypes because LPBC 148 was more frequent in HER2-positive or TNBC subtypes (Fig S1) . However, there were no significant differences in the means of three blood cell markers (ANC, ALC, and NLR) 150 between the cancer subtypes ( Fig S2) . Table 2 ). The subtypes, Ki-67 expression,
162
and NG were also found to be significant variables in identifying LPBC. 
IV. Discussion
169
In this study, we investigated whether peripheral blood cell counts are associated with
170
TILs in breast cancer. We hypothesized that TILs are associated with blood cell counts, which 171 reflect local and host immunity, respectively. To the best of our knowledge, this is the first 12 172 study investigating the relationship between TILs and blood cell markers. We found a 173 significantly reduced mean ANC in those with LPBC compared to those with non-LPBC.
174
Moreover, continuous ANC was a significant predictive factor of LPBC, independent of the 175 cancer subtypes.
176
The negative correlation observed between high ANC and LPBC in our study is 177 supported by the fact that neutrophils may act against the immune system via several 
192
We also found that LPBC was associated with the cancer subtypes; specifically, the 193 rate of LPBC was higher in the HER2 and TNBC subtypes are than that in the luminal/HER2-194 negative subtype. Another notable finding was that the Ki-67 labelling index was correlated 13 195 with LPBC, which may be explained by the fact that tumors with high Ki-67 labelling index
196
were more frequent in the HER2 or TNBC subtypes. These findings provide evidence that our 197 data is reliable.
198
Clinically, a previous study showed that high ANC could be a poor prognostic marker 
Acknowledgements
225
We acknowledge all authors in our paper. 
352
There were no significant differences in peripheral blood markers according to breast cancer 
